Alnylam Pharmaceuticals
ALNY
#571
Rank
A$58.24 B
Marketcap
A$439.19
Share price
-1.18%
Change (1 day)
14.36%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company